Trials / Completed
CompletedNCT00675220
Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™
A Prospective, Open-Labelled, Non-Controlled, Observational Study to Assess the Efficacy and Safety of NovoRapid™ FlexPen™ in the Treatment of Acute Hyperglycemia: A Post-Marketing Surveillance Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 373 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Asia. The aim of this observational study is to collect efficacy and safety data in diabetic patients with acute hyperglycemia using NovoRapid™ FlexPen™ as per normal clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | insulin aspart | Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2008-05-09
- Last updated
- 2016-10-28
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT00675220. Inclusion in this directory is not an endorsement.